Journal Article Summary
The article investigates the impact of low-dose aspirin on the ability of older adults to perform daily activities, which is crucial as many elderly individuals face challenges due to conditions like dementia and cerebrovascular events. Understanding whether aspirin can help maintain independence in daily living is important for improving the quality of life in aging populations. The study focuses on whether aspirin can reduce the incidence and persistence of disabilities in activities of daily living (ADLs) among community-dwelling older adults.
The research was part of the ASPREE trial, which involved over 19,000 healthy adults aged 70 and older (or 65 and older for U.S. minorities) from Australia and the United States. Participants were given either 100 mg of aspirin daily or a placebo, and their ability to perform six basic ADLs was assessed every six months over a median period of 4.7 years. The findings revealed that the rate of new ADL disabilities was similar between the aspirin and placebo groups, but those taking aspirin showed a lower rate of persistent ADL disabilities, suggesting that while aspirin may not prevent initial difficulties, it could help in reducing long-term disability.
However, the study has limitations, including the fact that it primarily involved healthy older adults, which may not represent those with existing health issues. Additionally, the increased mortality observed in the aspirin group following persistent ADL disability raises concerns about safety. Patients and caregivers should discuss these findings with healthcare professionals to understand the implications of aspirin use and consider individual health circumstances before making any decisions regarding aspirin therapy.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Woods Robyn L, Espinoza Sara, Thao Le T P, Ernst Michael E, Ryan Joanne, Wolfe Rory, Shah Raj C, Ward Stephanie A, et al.. Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2021. DOI: 10.1093/gerona/glaa316. PMID: 33367621. PMCID: PMC8514067.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
